Global Lateral Flow Rapid Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Lateral Flow Rapid Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Global Lateral Flow Rapid Testing market is projected to reach US$ 8346.3 million in 2033, increasing from US$ 5324 million in 2022, with the CAGR of 6.5% during the period of 2023 to 2033. Demand from Hospitals and Specialty Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lateral Flow Rapid Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Lateral Flow Rapid Testing key companies include Mologic, Thermo Fisher Scientific, Bio-Rad Laboratories, Svar Life Science, Abbott Laboratories, Roche, Danaher, Siemens Healthcare and BD, etc. Mologic, Thermo Fisher Scientific, Bio-Rad Laboratories are top 3 players and held % share in total in 2022.
Lateral Flow Rapid Testing can be divided into Sandwich Immunoassay and Competitive Immunoassay, etc. Sandwich Immunoassay is the mainstream product in the market, accounting for % share globally in 2022.
Lateral Flow Rapid Testing is widely used in various fields, such as Hospitals, Specialty Clinics, Diagnostic Centers and Others, etc. Hospitals provides greatest supports to the Lateral Flow Rapid Testing industry development. In 2022, global % share of Lateral Flow Rapid Testing went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lateral Flow Rapid Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Mologic
Thermo Fisher Scientific
Bio-Rad Laboratories
Svar Life Science
Abbott Laboratories
Roche
Danaher
Siemens Healthcare
BD
R-Biopharma
Cell Biolabs
BioMerieux
Merck
Qiagen
Abbott
PerkinElmer
Quidel Corporation
Danaher
IMMY
Segment by Type
Sandwich Immunoassay
Competitive Immunoassay
Hospitals
Specialty Clinics
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lateral Flow Rapid Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Lateral Flow Rapid Testing introduction, etc. Lateral Flow Rapid Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Lateral Flow Rapid Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
North America, Europe and Asia Pacific are the key regions for Lateral Flow Rapid Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Lateral Flow Rapid Testing key companies include Mologic, Thermo Fisher Scientific, Bio-Rad Laboratories, Svar Life Science, Abbott Laboratories, Roche, Danaher, Siemens Healthcare and BD, etc. Mologic, Thermo Fisher Scientific, Bio-Rad Laboratories are top 3 players and held % share in total in 2022.
Lateral Flow Rapid Testing can be divided into Sandwich Immunoassay and Competitive Immunoassay, etc. Sandwich Immunoassay is the mainstream product in the market, accounting for % share globally in 2022.
Lateral Flow Rapid Testing is widely used in various fields, such as Hospitals, Specialty Clinics, Diagnostic Centers and Others, etc. Hospitals provides greatest supports to the Lateral Flow Rapid Testing industry development. In 2022, global % share of Lateral Flow Rapid Testing went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lateral Flow Rapid Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Mologic
Thermo Fisher Scientific
Bio-Rad Laboratories
Svar Life Science
Abbott Laboratories
Roche
Danaher
Siemens Healthcare
BD
R-Biopharma
Cell Biolabs
BioMerieux
Merck
Qiagen
Abbott
PerkinElmer
Quidel Corporation
Danaher
IMMY
Segment by Type
Sandwich Immunoassay
Competitive Immunoassay
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lateral Flow Rapid Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Lateral Flow Rapid Testing introduction, etc. Lateral Flow Rapid Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Lateral Flow Rapid Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices